WHAT IS KNOWN ABOUT TUMOR PROLIFERATION RATES TO CHOOSE BETWEEN ACCELERATED FRACTIONATION OR HYPERFRACTIONATION

被引：168

作者：

TROTT, KR

KUMMERMEHR, J

机构：

来源：

关键词：

D O I：

10.1016/S0167-8140(85)80002-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1 / 9

页数：9

共 44 条

[1] BASERGA R, 1962, LAB INVEST, V11, P360
[2] BRENNER D, 1984, THESIS U MUNCHEN
[3] BUNEMANN H, 1973, STRAHLENTHER ONKOL, V146, P155
[4] COOPER E. H., 1966, EUR J CANCER, V2, P377, DOI 10.1016/0014-2964(66)90052-1
[5] IN-VITRO AND IN-VIVO LABELING OF ANIMAL TUMORS WITH TRITIATED-THYMIDINE
DENEKAMP, J
KALLMAN, RF
[J]. CELL AND TISSUE KINETICS, 1973, 6 (03): : 217 - 227
[6] ENTHAMMER G, 1978, THESIS U MUNCHEN
[7] ANALYSIS OF THE PARAMETERS RELATING TO FAILURES ABOVE THE CLAVICLES IN PATIENTS TREATED BY POSTOPERATIVE IRRADIATION FOR SQUAMOUS-CELL CARCINOMAS OF THE ORAL CAVITY OR OROPHARYNX
FELDMAN, M
FLETCHER, GH
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (01): : 27 - 30
[8] Fletcher G, 1980, TXB RADIOTHERAPY
[9] HODGKINS DISEASE - TUMOR LETHAL DOSE AND ISO-EFFECT RECOVERY CURVE
FRIEDMAN, M
PEARLMAN, AW
TURGEON, L
[J]. AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1967, 99 (04): : 843 - &
[10] HAINAU B, 1974, CANCER-AM CANCER SOC, V33, P115, DOI 10.1002/1097-0142(197401)33:1<115::AID-CNCR2820330118>3.0.CO